Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs

The functional state of adipocytes plays a central role in regulating numerous important metabolic functions, including energy and glucose homeostasis. While white adipocytes store excess calories as fat (triglycerides) and release free fatty acids as a fuel source in times of need, brown and beige...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2023-07, Vol.72 (7), p.825-834
Hauptverfasser: Liu, Liu, Wess, Jürgen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 834
container_issue 7
container_start_page 825
container_title Diabetes (New York, N.Y.)
container_volume 72
creator Liu, Liu
Wess, Jürgen
description The functional state of adipocytes plays a central role in regulating numerous important metabolic functions, including energy and glucose homeostasis. While white adipocytes store excess calories as fat (triglycerides) and release free fatty acids as a fuel source in times of need, brown and beige adipocytes (so-called thermogenic adipocytes) convert chemical energy stored in substrates (e.g., fatty acids or glucose) into heat, thus promoting energy expenditure. Like all other cell types, adipocytes express many G protein-coupled receptors (GPCRs) that are linked to four major functional classes of heterotrimeric G proteins (Gs, Gi/o, Gq/11, and G12/13). During the past few years, novel experimental approaches, including the use of chemogenetic strategies, have led to a series of important new findings regarding the metabolic consequences of activating or inhibiting distinct GPCR/G protein signaling pathways in white, brown, and beige adipocytes. This novel information should guide the development of novel drugs capable of modulating the activity of specific adipocyte GPCR signaling pathways for the treatment of obesity, type 2 diabetes, and related metabolic disorders.
doi_str_mv 10.2337/db23-0095
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10281224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2828913789</sourcerecordid><originalsourceid>FETCH-LOGICAL-c404t-962fa39cf2c8401a8829eca631b32cb0d8865059815b8235d4297abbabd0cb963</originalsourceid><addsrcrecordid>eNpdkUtLxDAUhYMoOj4W_gEJuNFFNcntI1nJMD5BVGREdyFJ0zHSaWrSCv57O46KShZ3cT4OJ3wI7VJyxACK41IzSAgR2QoaUQEiAVY8raIRIZQltBDFBtqM8YUQkg9vHW1AASAggxF6HJeu9ea9s_gC3wXfWdckE9-3tS3xvTW27XyIWEV8N2RN51SNpyrMbBdx5QO-8W-2xuMhKJ3StnMGn4Z-FrfRWqXqaHe-7hZ6OD-bTi6T69uLq8n4OjEpSbtE5KxSIEzFDE8JVZwzYY3KgWpgRpOS8zwjmeA005xBVqZMFEprpUtitMhhC50se9tez21pholB1bINbq7Cu_TKyb9J457lzL9JShinjKVDw8FXQ_CvvY2dnLtobF2rxvo-SsYZhxyyYoHu_0NffB-a4X-flKBQcDFQh0vKBB9jsNXPGkrkwpdc-JILXwO793v-D_ktCD4AHGmQSw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2828913789</pqid></control><display><type>article</type><title>Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Liu, Liu ; Wess, Jürgen</creator><creatorcontrib>Liu, Liu ; Wess, Jürgen</creatorcontrib><description>The functional state of adipocytes plays a central role in regulating numerous important metabolic functions, including energy and glucose homeostasis. While white adipocytes store excess calories as fat (triglycerides) and release free fatty acids as a fuel source in times of need, brown and beige adipocytes (so-called thermogenic adipocytes) convert chemical energy stored in substrates (e.g., fatty acids or glucose) into heat, thus promoting energy expenditure. Like all other cell types, adipocytes express many G protein-coupled receptors (GPCRs) that are linked to four major functional classes of heterotrimeric G proteins (Gs, Gi/o, Gq/11, and G12/13). During the past few years, novel experimental approaches, including the use of chemogenetic strategies, have led to a series of important new findings regarding the metabolic consequences of activating or inhibiting distinct GPCR/G protein signaling pathways in white, brown, and beige adipocytes. This novel information should guide the development of novel drugs capable of modulating the activity of specific adipocyte GPCR signaling pathways for the treatment of obesity, type 2 diabetes, and related metabolic disorders.</description><identifier>ISSN: 0012-1797</identifier><identifier>ISSN: 1939-327X</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db23-0095</identifier><identifier>PMID: 37339353</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Adipocytes ; Adipocytes, Beige - metabolism ; Adipocytes, Brown - metabolism ; Adipocytes, White - metabolism ; Antidiabetics ; Calories ; Diabetes ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - metabolism ; Drug development ; Energy expenditure ; Energy Metabolism ; Fatty acids ; G protein-coupled receptors ; Glucose - metabolism ; Homeostasis ; Humans ; Hypoglycemic Agents - metabolism ; Hypoglycemic Agents - pharmacology ; Hypoglycemic Agents - therapeutic use ; Metabolic disorders ; Metabolism ; Precision medicine ; Proteins ; Receptors, G-Protein-Coupled - metabolism ; s in Diabetes ; Signal transduction ; Thermogenesis ; Triglycerides</subject><ispartof>Diabetes (New York, N.Y.), 2023-07, Vol.72 (7), p.825-834</ispartof><rights>2023 by the American Diabetes Association.</rights><rights>Copyright American Diabetes Association Jul 2023</rights><rights>2023 by the American Diabetes Association 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c404t-962fa39cf2c8401a8829eca631b32cb0d8865059815b8235d4297abbabd0cb963</citedby><cites>FETCH-LOGICAL-c404t-962fa39cf2c8401a8829eca631b32cb0d8865059815b8235d4297abbabd0cb963</cites><orcidid>0000-0003-0818-1232</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281224/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281224/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37339353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Liu</creatorcontrib><creatorcontrib>Wess, Jürgen</creatorcontrib><title>Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>The functional state of adipocytes plays a central role in regulating numerous important metabolic functions, including energy and glucose homeostasis. While white adipocytes store excess calories as fat (triglycerides) and release free fatty acids as a fuel source in times of need, brown and beige adipocytes (so-called thermogenic adipocytes) convert chemical energy stored in substrates (e.g., fatty acids or glucose) into heat, thus promoting energy expenditure. Like all other cell types, adipocytes express many G protein-coupled receptors (GPCRs) that are linked to four major functional classes of heterotrimeric G proteins (Gs, Gi/o, Gq/11, and G12/13). During the past few years, novel experimental approaches, including the use of chemogenetic strategies, have led to a series of important new findings regarding the metabolic consequences of activating or inhibiting distinct GPCR/G protein signaling pathways in white, brown, and beige adipocytes. This novel information should guide the development of novel drugs capable of modulating the activity of specific adipocyte GPCR signaling pathways for the treatment of obesity, type 2 diabetes, and related metabolic disorders.</description><subject>Adipocytes</subject><subject>Adipocytes, Beige - metabolism</subject><subject>Adipocytes, Brown - metabolism</subject><subject>Adipocytes, White - metabolism</subject><subject>Antidiabetics</subject><subject>Calories</subject><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Drug development</subject><subject>Energy expenditure</subject><subject>Energy Metabolism</subject><subject>Fatty acids</subject><subject>G protein-coupled receptors</subject><subject>Glucose - metabolism</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Hypoglycemic Agents - metabolism</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Metabolic disorders</subject><subject>Metabolism</subject><subject>Precision medicine</subject><subject>Proteins</subject><subject>Receptors, G-Protein-Coupled - metabolism</subject><subject>s in Diabetes</subject><subject>Signal transduction</subject><subject>Thermogenesis</subject><subject>Triglycerides</subject><issn>0012-1797</issn><issn>1939-327X</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtLxDAUhYMoOj4W_gEJuNFFNcntI1nJMD5BVGREdyFJ0zHSaWrSCv57O46KShZ3cT4OJ3wI7VJyxACK41IzSAgR2QoaUQEiAVY8raIRIZQltBDFBtqM8YUQkg9vHW1AASAggxF6HJeu9ea9s_gC3wXfWdckE9-3tS3xvTW27XyIWEV8N2RN51SNpyrMbBdx5QO-8W-2xuMhKJ3StnMGn4Z-FrfRWqXqaHe-7hZ6OD-bTi6T69uLq8n4OjEpSbtE5KxSIEzFDE8JVZwzYY3KgWpgRpOS8zwjmeA005xBVqZMFEprpUtitMhhC50se9tez21pholB1bINbq7Cu_TKyb9J457lzL9JShinjKVDw8FXQ_CvvY2dnLtobF2rxvo-SsYZhxyyYoHu_0NffB-a4X-flKBQcDFQh0vKBB9jsNXPGkrkwpdc-JILXwO793v-D_ktCD4AHGmQSw</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Liu, Liu</creator><creator>Wess, Jürgen</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0818-1232</orcidid></search><sort><creationdate>20230701</creationdate><title>Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs</title><author>Liu, Liu ; Wess, Jürgen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c404t-962fa39cf2c8401a8829eca631b32cb0d8865059815b8235d4297abbabd0cb963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adipocytes</topic><topic>Adipocytes, Beige - metabolism</topic><topic>Adipocytes, Brown - metabolism</topic><topic>Adipocytes, White - metabolism</topic><topic>Antidiabetics</topic><topic>Calories</topic><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Drug development</topic><topic>Energy expenditure</topic><topic>Energy Metabolism</topic><topic>Fatty acids</topic><topic>G protein-coupled receptors</topic><topic>Glucose - metabolism</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Hypoglycemic Agents - metabolism</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Metabolic disorders</topic><topic>Metabolism</topic><topic>Precision medicine</topic><topic>Proteins</topic><topic>Receptors, G-Protein-Coupled - metabolism</topic><topic>s in Diabetes</topic><topic>Signal transduction</topic><topic>Thermogenesis</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Liu</creatorcontrib><creatorcontrib>Wess, Jürgen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Liu</au><au>Wess, Jürgen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>72</volume><issue>7</issue><spage>825</spage><epage>834</epage><pages>825-834</pages><issn>0012-1797</issn><issn>1939-327X</issn><eissn>1939-327X</eissn><abstract>The functional state of adipocytes plays a central role in regulating numerous important metabolic functions, including energy and glucose homeostasis. While white adipocytes store excess calories as fat (triglycerides) and release free fatty acids as a fuel source in times of need, brown and beige adipocytes (so-called thermogenic adipocytes) convert chemical energy stored in substrates (e.g., fatty acids or glucose) into heat, thus promoting energy expenditure. Like all other cell types, adipocytes express many G protein-coupled receptors (GPCRs) that are linked to four major functional classes of heterotrimeric G proteins (Gs, Gi/o, Gq/11, and G12/13). During the past few years, novel experimental approaches, including the use of chemogenetic strategies, have led to a series of important new findings regarding the metabolic consequences of activating or inhibiting distinct GPCR/G protein signaling pathways in white, brown, and beige adipocytes. This novel information should guide the development of novel drugs capable of modulating the activity of specific adipocyte GPCR signaling pathways for the treatment of obesity, type 2 diabetes, and related metabolic disorders.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>37339353</pmid><doi>10.2337/db23-0095</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-0818-1232</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2023-07, Vol.72 (7), p.825-834
issn 0012-1797
1939-327X
1939-327X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10281224
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adipocytes
Adipocytes, Beige - metabolism
Adipocytes, Brown - metabolism
Adipocytes, White - metabolism
Antidiabetics
Calories
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - metabolism
Drug development
Energy expenditure
Energy Metabolism
Fatty acids
G protein-coupled receptors
Glucose - metabolism
Homeostasis
Humans
Hypoglycemic Agents - metabolism
Hypoglycemic Agents - pharmacology
Hypoglycemic Agents - therapeutic use
Metabolic disorders
Metabolism
Precision medicine
Proteins
Receptors, G-Protein-Coupled - metabolism
s in Diabetes
Signal transduction
Thermogenesis
Triglycerides
title Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T12%3A29%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adipocyte%20G%20Protein-Coupled%20Receptors%20as%20Potential%20Targets%20for%20Novel%20Antidiabetic%20Drugs&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=Liu,%20Liu&rft.date=2023-07-01&rft.volume=72&rft.issue=7&rft.spage=825&rft.epage=834&rft.pages=825-834&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db23-0095&rft_dat=%3Cproquest_pubme%3E2828913789%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2828913789&rft_id=info:pmid/37339353&rfr_iscdi=true